Ono Pharmaceutical - 24 Year Stock Price History | OPHLF

Historical daily share price chart and data for Ono Pharmaceutical since 2002 adjusted for splits and dividends. The latest closing stock price for Ono Pharmaceutical as of January 08, 2026 is 14.00.

The all-time high Ono Pharmaceutical stock closing price was 36.00 on April 25, 2016.
The Ono Pharmaceutical 52-week high stock price is 14.00, which is 0% above the current share price.
The Ono Pharmaceutical 52-week low stock price is 9.20, which is 34.3% below the current share price.
The average Ono Pharmaceutical stock price for the last 52 weeks is 11.02.

Ono Pharmaceutical Historical Annual Stock Price Data
Year	Average Stock Price	Year Open	Year High	Year Low	Year Close	Annual % Change
2026	14.0000	14.0000	14.0000	14.0000	14.0000	8.78%
2025	10.8213	10.5323	13.2800	8.9583	12.8696	37.97%
2024	12.7504	15.5012	15.5012	8.9680	9.3275	-42.77%
2023	17.5698	18.5236	19.9331	15.3538	16.2984	-20.39%
2022	21.3343	21.3244	24.2496	20.1069	20.4730	-5.58%
2021	20.7102	24.5731	25.1662	17.8165	21.6838	-11.76%
2020	23.9792	18.2995	26.2678	14.9723	24.5731	60.75%
2019	14.9043	15.2096	15.2868	14.2230	15.2868	-34.79%
2018	21.0096	20.2702	23.4411	18.6908	23.4411	31.44%
2017	17.4379	16.1721	18.5149	16.1721	17.8336	-11.10%
2016	27.3376	26.5898	36.0009	19.7852	20.0613	-24.99%
2015	19.9599	15.8654	26.7435	15.8654	26.7435	108.64%
2014	13.5457	13.2668	14.3774	12.8182	12.8182	6.56%
2013	9.3553	7.6461	12.0296	7.6244	12.0296	52.43%
2012	8.4111	7.6235	9.0231	7.6235	7.8918	16.59%
2011	7.0792	6.1788	8.1099	6.1788	6.7687	9.90%
2010	5.7982	5.8131	6.1588	5.2725	6.1588	-6.91%
2009	5.6978	5.2976	6.6159	5.2976	6.6159	20.84%
2008	5.9330	5.6698	6.5835	5.4747	5.4747	0.19%
2007	6.1283	6.5195	6.5195	5.4642	5.4642	-0.69%
2006	5.3147	5.1756	5.5848	4.8698	5.5024	7.49%
2005	5.3542	5.7407	5.8098	4.8019	5.1190	-4.07%
2004	5.1413	5.2969	5.3361	4.9437	5.3361	26.40%
2003	3.7732	3.5174	4.2217	3.5174	4.2217	18.13%

Sector	Industry	Market Cap	Revenue
Medical	Medical - Drug Manufacturing	$6.576B	$3.197B
Ono Pharmaceuticals produces, purchases and sells pharmaceuticals and diagnostic reagents focusing primarily on prescription pharmaceuticals.

Stock Name	Country	Market Cap	PE Ratio
Chugai Pharmaceutical (CHGCY)	Japan	$88.134B	33.47
Zoetis (ZTS)	United States	$55.457B	19.85
Takeda Pharmaceutical (TAK)	Japan	$52.407B	10.69
Daiichi Sankyo, - (DSNKY)	Japan	$40.558B	20.20
BeOne Medicines - (ONC)	Switzerland	$38.026B	201.60
Sandoz Group AG (SDZNY)	Switzerland	$33.757B	0.00
United Therapeutics (UTHR)	United States	$20.483B	18.03
Merck (MKKGY)	Germany	$19.238B	11.86
Shionogi (SGIOY)	Japan	$15.687B	14.41
Summit Therapeutics (SMMT)	United States	$13.611B	0.00
Neurocrine Biosciences (NBIX)	United States	$13.493B	32.38
Ionis Pharmaceuticals (IONS)	United States	$12.775B	0.00
IPSEN (IPSEY)	France	$12.596B	0.00
Madrigal Pharmaceuticals (MDGL)	United States	$11.474B	0.00
Orion OYJ (ORINY)	Finland	$10.204B	29.15
Eisai (ESAIY)		$8.539B	0.00
Grifols, S.A (GRFS)	Spain	$6.353B	0.00
Stevanato Group S.p.A (STVN)	Italy	$6.196B	34.68
Crinetics Pharmaceuticals (CRNX)	United States	$5.259B	0.00
Hikma Pharmaceuticals Plc (HKMPF)	United Kingdom	$4.613B	0.00
Indivior (INDV)	United States	$4.204B	17.16
AMNEAL PHARMACEUTICALS, INC (AMRX)	United States	$4.165B	19.78
Corcept Therapeutics (CORT)	United States	$3.896B	42.09
NewAmsterdam Pharma (NAMS)	Netherlands	$3.619B	0.00
Centessa Pharmaceuticals (CNTA)	United Kingdom	$2.969B	0.00
Catalyst Pharmaceuticals (CPRX)	United States	$2.848B	9.09
Hypermarcas (HYPMY)	Brazil	$2.717B	18.65
Dyne Therapeutics (DYN)	United States	$2.492B	0.00
Ocular Therapeutix (OCUL)	United States	$2.358B	0.00
Soleno Therapeutics (SLNO)	United States	$2.281B	0.00
Avadel Pharmaceuticals (AVDL)	Ireland	$2.100B	0.00
Aurinia Pharmaceuticals Inc (AUPH)	Canada	$2.008B	23.80
Guardian Pharmacy Services (GRDN)	United States	$1.908B	36.74
Harrow (HROW)	United States	$1.784B	109.46
Ardelyx (ARDX)	United States	$1.674B	0.00
Oruka Therapeutics (ORKA)	United States	$1.549B	0.00
Enliven Therapeutics (ELVN)	United States	$1.546B	0.00
Amylyx Pharmaceuticals (AMLX)	United States	$1.545B	0.00
Collegium Pharmaceutical (COLL)	United States	$1.472B	7.29
BioCryst Pharmaceuticals (BCRX)	United States	$1.429B	84.75
Relay Therapeutics (RLAY)	United States	$1.399B	0.00
Evotec AG (EVO)	Germany	$1.314B	0.00
Xeris Biopharma Holdings (XERS)	United States	$1.258B	0.00
Savara (SVRA)	United States	$1.221B	0.00
ARS Pharmaceuticals (SPRY)	United States	$1.165B	0.00
Theravance Biopharma (TBPH)	United States	$1.044B	43.85
Xencor (XNCR)	United States	$1.032B	0.00
Cronos Group (CRON)	Canada	$1.006B	0.00
Esperion Therapeutics (ESPR)	United States	$0.772B	0.00
KalVista Pharmaceuticals (KALV)	United States	$0.770B	0.00
Ironwood Pharmaceuticals (IRWD)	United States	$0.739B	17.46
Nektar Therapeutics (NKTR)	United States	$0.734B	0.00
Rigel Pharmaceuticals (RIGL)	United States	$0.710B	6.34
ProKidney (PROK)	United States	$0.686B	0.00
Bioventus (BVS)	United States	$0.641B	13.12
Lexeo Therapeutics (LXEO)	United States	$0.563B	0.00
Zevra Therapeutics (ZVRA)	United States	$0.516B	0.00
Elite Pharmaceuticals (ELTP)	United States	$0.513B	0.00
4D Molecular Therapeutics (FDMT)	United States	$0.501B	0.00
Lyell Immunopharma (LYEL)	United States	$0.498B	0.00
Organogenesis (ORGO)	United States	$0.491B	0.00
Siga Technologies (SIGA)	United States	$0.481B	6.59
Altimmune (ALT)	United States	$0.436B	0.00
Aquestive Therapeutics (AQST)	United States	$0.429B	0.00
Nature's Sunshine Products (NATR)	United States	$0.389B	23.18
USANA Health Sciences (USNA)	United States	$0.374B	10.45
Akebia Therapeutics (AKBA)	United States	$0.366B	0.00
Avalo Therapeutics (AVTX)	United States	$0.300B	0.00
Achieve Life Sciences (ACHV)	Canada	$0.299B	0.00
Aclaris Therapeutics (ACRS)	United States	$0.297B	0.00
Larimar Therapeutics (LRMR)	United States	$0.282B	0.00
Relmada Therapeutics (RLMD)	United States	$0.282B	0.00
Silence Therapeutics (SLN)	United Kingdom	$0.277B	0.00
Profound Medical (PROF)	Canada	$0.277B	0.00
Fractyl Health (GUTS)	United States	$0.275B	0.00
OmniAb (OABI)	United States	$0.275B	0.00
Heron Therapeutics (HRTX)	United States	$0.273B	0.00
Aldeyra Therapeutics (ALDX)	United States	$0.255B	0.00
Protara Therapeutics (TARA)	United States	$0.255B	0.00
Enlivex Therapeutics (ENLV)	Israel	$0.229B	0.00
Journey Medical (DERM)	United States	$0.213B	0.00
Tonix Pharmaceuticals Holding (TNXP)	United States	$0.206B	0.00
Galectin Therapeutics (GALT)	United States	$0.193B	0.00
MediWound (MDWD)	Israel	$0.189B	0.00
Minerva Neurosciences (NERV)	United States	$0.187B	0.00
Innate Pharma SA (IPHYF)	France	$0.181B	0.00
Century Therapeutics (IPSC)	United States	$0.177B	0.00
Surrozen (SRZN)	United States	$0.171B	0.00
AleAnna (ANNA)	United States	$0.167B	0.00
Procaps Group, S.A (PROCF)	Luxembourg	$0.161B	0.00
Corbus Pharmaceuticals Holdings (CRBP)	United States	$0.145B	0.00
Context Therapeutics (CNTX)	United States	$0.144B	0.00
Prelude Therapeutics (PRLD)	United States	$0.142B	0.00
Unicycive Therapeutics (UNCY)	United States	$0.142B	0.00
Incannex Healthcare (IXHL)	Australia	$0.135B	0.00
VAXART, INC (VXRT)	United States	$0.132B	0.00
Karyopharm Therapeutics (KPTI)	United States	$0.132B	0.00
Inhibikase Therapeutics (IKT)	United States	$0.128B	0.00
Verrica Pharmaceuticals (VRCA)	United States	$0.127B	0.00
Pyxis Oncology (PYXS)	United States	$0.124B	0.00
Avita Medical (RCEL)	United States	$0.107B	0.00
Cassava Sciences (SAVA)	United States	$0.104B	0.00
Champions Oncology (CSBR)	United States	$0.100B	42.24
Cardiol Therapeutics (CRDL)	Canada	$0.097B	0.00
Vivani Medical (VANI)	United States	$0.093B	0.00
Korro Bio (KRRO)	United States	$0.085B	0.00
Gain Therapeutics (GANX)	United States	$0.085B	0.00
Cumberland Pharmaceuticals (CPIX)	United States	$0.073B	61.00
PolyPid (PYPD)	Israel	$0.069B	0.00
Dominari Holdings (DOMH)	United States	$0.069B	0.00
Rafael Holdings (RFL)	United States	$0.066B	0.00
Arch Biopartners (ACHFF)	Canada	$0.066B	0.00
Assertio Holdings (ASRT)	United States	$0.066B	0.00
Metagenomi (MGX)	United States	$0.065B	0.00
NRx Pharmaceuticals (NRXP)	United States	$0.064B	0.00
Lipocine (LPCN)	United States	$0.061B	0.00
PMV Pharmaceuticals (PMVP)	United States	$0.061B	0.00
Acrivon Therapeutics (ACRV)	United States	$0.058B	0.00
Lite Strategy (LITS)	United States	$0.057B	0.00
ElectroCore (ECOR)	United States	$0.052B	0.00
Nutriband (NTRB)	United States	$0.052B	0.00
Talphera (TLPH)	United States	$0.048B	0.00
Telomir Pharmaceuticals (TELO)	United States	$0.046B	0.00
Plus Therapeutics (PSTV)	United States	$0.040B	0.00
Reviva Pharmaceuticals Holdings (RVPH)	United States	$0.040B	0.00
FibroGen (FGEN)	United States	$0.039B	0.00
Kyntra Bio Inc (KYNB)	United States	$0.038B	0.00
Wellgistics Health (WGRX)	United States	$0.037B	0.00
Mural Oncology (MURA)	Ireland	$0.035B	0.00
MARKER THERAPEUTICS, INC (MRKR)	United States	$0.030B	0.00
Natural Alternatives (NAII)	United States	$0.029B	0.00
Jupiter Neurosciences (JUNS)	United States	$0.028B	0.00
SCYNEXIS (SCYX)	United States	$0.027B	0.00
TherapeuticsMD (TXMD)	United States	$0.025B	0.00
Klotho Neurosciences (KLTO)	United States	$0.022B	0.00
Scienture Holdings (SCNX)	United States	$0.021B	0.00
Inotiv (NOTV)	United States	$0.021B	0.00
Liminatus Pharma (LIMN)	United States	$0.020B	0.00
VYNE Therapeutics (VYNE)	United States	$0.019B	0.00
Vivos Therapeutics (VVOS)	United States	$0.019B	0.00
Citius Pharmaceuticals (CTXR)	United States	$0.018B	0.00
Iterum Therapeutics (ITRM)	Ireland	$0.017B	0.00
Vyome Holdings (HIND)	United States	$0.017B	0.00
Cosmos Health (COSM)	United States	$0.017B	0.00
Mannatech (MTEX)	United States	$0.014B	0.00
Traws Pharma (TRAW)	United States	$0.014B	0.02
Tempest Therapeutics (TPST)	United States	$0.013B	0.00
CASI Pharmaceuticals (CASI)	China	$0.013B	0.00
BioLineRx (BLRX)	Israel	$0.012B	0.00
Phio Pharmaceuticals (PHIO)	United States	$0.012B	0.00
China SXT Pharmaceuticals (SXTC)	China	$0.011B	0.00
Mangoceuticals (MGRX)	United States	$0.011B	0.00
Curanex Pharmaceuticals Inc (CURX)	United States	$0.010B	0.00
Addex Therapeutics (ADXN)	Switzerland	$0.010B	0.00
Ernexa Therapeutics (ERNA)	United States	$0.010B	0.00
Quoin Pharmaceuticals (QNRX)	United States	$0.009B	0.00
Nuvilex (PMCB)	United States	$0.009B	0.00
Ainos (AIMD)	United States	$0.009B	0.00
BioVie (BIVI)	United States	$0.009B	0.00
XTL Biopharmaceuticals (XTLB)	Israel	$0.008B	0.00
TransCode Therapeutics (RNAZ)	United States	$0.008B	0.00
Kiora Pharmaceuticals (KPRX)	United States	$0.008B	0.00
Biomerica (BMRA)	United States	$0.008B	0.00
Heatwurx (PCSA)	United States	$0.008B	0.00
Aptorum Group (APM)	United Kingdom	$0.007B	0.00
Indaptus Therapeutics (INDP)	United States	$0.006B	0.00
Alaunos Therapeutics (TCRT)	United States	$0.006B	0.00
Redhill Biopharma (RDHL)	Israel	$0.006B	0.00
Sonoma Pharmaceuticals (SNOA)	United States	$0.006B	0.00
Decoy Therapeutics Inc (DCOY)	United States	$0.006B	0.00
Xenetic Biosciences (XBIO)	United States	$0.005B	0.00
Salarius Pharmaceuticals (SLRX)	United States	$0.005B	0.00
XORTX Therapeutics (XRTX)	Canada	$0.004B	0.00
Clearmind Medicine (CMND)	Canada	$0.004B	0.00
Lyra Therapeutics (LYRA)	United States	$0.003B	0.00
InMed Pharmaceuticals (INM)	Canada	$0.003B	0.00
Jaguar Animal Health (JAGX)	United States	$0.003B	0.00
Shuttle Pharmaceuticals Holdings (SHPH)	United States	$0.002B	0.00
Universe Pharmaceuticals INC (UPC)	China	$0.002B	0.00
CDT Equity (CDT)	United States	$0.002B	0.00
60 Degrees Pharmaceuticals (SXTP)	United States	$0.002B	0.00
PainReform (PRFX)	Israel	$0.002B	0.00
Galmed Pharmaceuticals (GLMD)	Israel	$0.001B	0.00
SciSparc (SPRC)	Israel	$0.001B	0.00
Aditxt (ADTX)	United States	$0.001B	0.00
Emisphere Technologies (EMIS)	United States	$0.000B	0.00
4D Pharma (LBPS)	United Kingdom	$0.000B	0.00
Patheon (PTHN)	Netherlands	$0.000B	0.00
RVL Pharmaceuticals (RVLP)	United States	$0.000B	0.00